Office of Special Health Issues (OSHI)
Mission Statement
The Office of Special Health Issues works with patients, patient advocates,
and health professional organizations to encourage and support their active
participation in the forming of the Food and Drug Administration's (FDA)
regulatory policy. The staff is familiar with the concerns confronting patients
and families dealing with a life-threatening illness.
We serve the public by answering their questions and concerns related to HIV/AIDS,
cancer, and other Special Health Issues.
We also provide information about the FDA drug approval process and clinical
trials.
Some of our responsibilities include:
- serving as a channel through which patient and health care professional
issues and viewpoints can be brought to the attention of FDA medical and
regulatory staff
- ensuring a comprehensive and timely response to individuals with questions
and concerns related to life-threatening diseases and other special health
issues
- participating in the development of national policies and practices concerning
HIV/AIDS, Cancer, and issues related to
Special Populations, such as racial/ethnic groups, pediatrics,
and gender specific concerns
- collaborating
with health professional organizations to pursue mutual interests and initiatives
around medical product safety and communication
- providing information about the FDA drug approval process and clinical
trials
- providing FDA representation at scientific and policy meetings related to
life-threatening diseases and other special health concerns
For more information, contact the Office of Special
Health Issues.
![horizontal rule](https://webarchive.library.unt.edu/web/20090511210143im_/http://www.fda.gov/graphics/blkpixel.gif)